For weight management specifically, semaglutide (Wegovy, also approved for adolescents 12 years), liraglutide 3 mg (Saxenda), and tirzepatide (Zepbound) have received FDA approval
10.3803/EnM.2021.1155 79 JourdanJ
Extensively studied since the 1980s, BPC-157 has demonstrated benefits for: Its often called a "healing accelerator" because of how efficiently it supports the bodys natural repair systems
M.TeperA.FernandezC.ZouJ.et al (2022)
In a randomized controlled trial involving patients with cirrhosis and CHE, dietary intervention with protein intake of 1.01.5 g/kg/day led to significant improvement in CHE and was associated with more favorable clinical outcomes compared with a standard diet [118]
Using a soft towel, pat your skin dry